placeholder image
M. C. Riddle All authors
Publications While At HealthPartners
selected publications
Journal Article
  • Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)
    Diabetes, Obesity & Metabolism. 2018
  • Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naive people with type 2 diabetes: 12-month results from the EDITION 3 trial
    Diabetes and Metabolism. 2017
  • Efficacy and safety of flexible versus fixed dosing intervals of insulin glargine 300 U/mL in people with type 2 diabetes
    Diabetes Technology & Therapeutics. 2016
  • Design of FLAT-SUGAR: randomized trial of prandial insulin versus prandial GLP-1 receptor agonist together with basal insulin and metformin for high-risk type 2 diabetes
    Diabetes care. 2015
  • Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension
    Diabetes, Obesity & Metabolism. 2015
  • Insulin dose and cardiovascular mortality in the ACCORD Trial
    Diabetes care. 2015
  • New insulin Glargine 300 Units/mL versus Glargine 100 Units/mL in people with type 1 diabetes: a randomized, phase 3a, open-label clinical trial (EDITION 4)
    Diabetes care. 2015
  • New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naive people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
    Diabetes, Obesity & Metabolism. 2015
  • Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial
    Diabetologia. 2014
  • New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2)
    Diabetes care. 2014
  • Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial
    Diabetes care. 2014
  • International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece
    Diabetes Technology & Therapeutics. 2011
  • Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial
    Diabetes care. 2010
  • Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
    Diabetes care. 2005
  • Contact
    full name
  • M. C. Riddle
  • MC Riddle
  • Quick Info